NuCana PLC (NCNA)
3.98
+0.02
(+0.51%)
USD |
NASDAQ |
May 01, 16:00
3.85
-0.13
(-3.27%)
After-Hours: 20:00
NuCana Cash from Investing (TTM): 3.594M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 3.594M |
September 30, 2023 | 3.786M |
June 30, 2023 | 0.5386M |
March 31, 2023 | 0.5279M |
December 31, 2022 | 0.1486M |
September 30, 2022 | -0.6746M |
June 30, 2022 | -4.640M |
March 31, 2022 | -4.918M |
December 31, 2021 | -4.899M |
September 30, 2021 | -4.498M |
June 30, 2021 | -1.433M |
March 31, 2021 | -1.565M |
December 31, 2020 | -1.685M |
Date | Value |
---|---|
September 30, 2020 | -1.518M |
June 30, 2020 | -0.6826M |
March 31, 2020 | -0.4853M |
December 31, 2019 | -0.1851M |
September 30, 2019 | -0.4224M |
June 30, 2019 | -0.4685M |
March 31, 2019 | -0.7057M |
December 31, 2018 | -0.8686M |
September 30, 2018 | -0.745M |
June 30, 2018 | -1.266M |
March 31, 2018 | -1.115M |
December 31, 2017 | -1.205M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-4.918M
Minimum
Mar 2022
3.786M
Maximum
Sep 2023
-1.025M
Average
-0.6746M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
Adaptimmune Therapeutics PLC | 176.54M |
Biodexa Pharmaceuticals Plc | -0.3289M |
Autolus Therapeutics PLC | -10.99M |
Mereo BioPharma Group PLC | -0.419M |
Bicycle Therapeutics PLC | -2.929M |